Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.

[1]  C. Tromeur,et al.  Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis , 2021, Thrombosis and Haemostasis.

[2]  C. Tromeur,et al.  Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies. , 2021, Thrombosis research.

[3]  P. Kolh,et al.  European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. , 2020, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  B. Kevane,et al.  Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? , 2020, Blood advances.

[5]  Tim Friede,et al.  Estimating and comparing adverse event probabilities in the presence of varying follow‐up times and competing events , 2020, Pharmaceutical statistics.

[6]  R. Otero,et al.  Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[7]  P. Simioni,et al.  Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma , 2018, Cancers.

[8]  M. Monreal,et al.  Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism. , 2018, The American journal of medicine.

[9]  A. Folsom,et al.  Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study , 2018, Journal of thrombosis and haemostasis : JTH.

[10]  J. Přeček,et al.  Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  S. Schulman.  How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. , 2017, Blood.

[12]  Jhi-Joung Wang,et al.  Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events , 2017, Journal of the American Heart Association.

[13]  P. Prandoni,et al.  The impact of deep vein thrombosis on the risk of subsequent cardiovascular events: a 14-year follow-up study. , 2017, International angiology : a journal of the International Union of Angiology.

[14]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials , 2015, Journal of Nuclear Cardiology.

[15]  P. Prandoni,et al.  Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism. , 2015, Journal of vascular surgery. Venous and lymphatic disorders.

[16]  P. Palczewski,et al.  Patent foramen ovale increases the risk of acute ischemic stroke in patients with acute pulmonary embolism leading to right ventricular dysfunction. , 2014, Thrombosis research.

[17]  K. Bailey,et al.  Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies. , 2014, Thrombosis research.

[18]  J. Badimón,et al.  Pathophysiology of Acute Coronary Syndrome , 2014, Current Atherosclerosis Reports.

[19]  S. Kaatz,et al.  Risk factors associated with myocardial infarction in venous thromboembolism patients , 2014, Current medical research and opinion.

[20]  S. Braekkan,et al.  Epidemiology of cancer-associated venous thrombosis. , 2013, Blood.

[21]  F. Rosendaal,et al.  Increased risk of CVD after VT is determined by common etiologic factors. , 2013, Blood.

[22]  C. Tromeur,et al.  Lipid lowering drugs and the risk of recurrent venous thromboembolism. , 2012, Thrombosis research.

[23]  Charles P. Lin,et al.  Myocardial infarction accelerates atherosclerosis , 2012, Nature.

[24]  W. Ageno,et al.  Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[25]  J. Badimón,et al.  Thrombi of Different Pathologies: Implications for Diagnosis and Treatment , 2010, Current Treatment Options in Cardiovascular Medicine.

[26]  H. Bilo,et al.  eGFR and creatinine clearance in relation to metabolic changes in an unselected patient population. , 2009, European journal of internal medicine.

[27]  D. Alter,et al.  The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction , 2008, Journal of thrombosis and haemostasis : JTH.

[28]  E. Horváth-Puhó,et al.  Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study , 2007, The Lancet.

[29]  E. Oger,et al.  Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital‐based case–control study , 2006, Journal of thrombosis and haemostasis : JTH.

[30]  M. Math,et al.  Noninvasive Diagnosis of Deep Venous Thrombosis , 1998, Annals of Internal Medicine.

[31]  Akshay S. Desai,et al.  2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. , 2018, Journal of the American College of Cardiology.

[32]  S. Konstantinides.  Clinical practice. Acute pulmonary embolism. , 2008, The New England journal of medicine.

[33]  W. Ageno,et al.  A prospective study on cardiovascular events after acute pulmonary embolism , 2005 .

[34]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.